← Eichor
Condition: Nec Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nec

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

PrePhage - Faecal Bacteriophage Transfer for Enhanced Gastrointestinal Tract Maturation in Preterm Infants
EARLY_Phase 1 · 1 location(s) · Rigshospitalet, Denmark · NCT05272579A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)
Phase 1/Phase 2 · 15 location(s) · Phanes Therapeutics · NCT05652686Study Investigating Tarlatamab (AMG 757) in Patients With Metastatic/Locally Advanced Small-Cell Lung Cancer (SCLC) and
Phase 2 · 1 location(s) · Gustave Roussy, Cancer Campus, Grand Paris · NCT07016230Impact of Standardized Skin-to-Skin Care on Clinical Outcomes in Infants Born ≤ 32 Weeks: A Multicenter Study
NA · 1 location(s) · Baskent University Ankara Hospital · NCT06672913Sintilimab Combined With IBI310 and Surufatinib for the Treatment of G3-NET and NEC (NESSIE)
Phase 2 · 2 location(s) · Peking University · NCT05165407A Clinical Trial of LBL-024 Combined With Etoposide and Platinum in Patients With Advanced Neuroendocrine Carcinoma
Phase 1/Phase 2 · 25 location(s) · Nanjing Leads Biolabs Co.,Ltd · NCT06157827A Study of IDE849 in Patients With DLL3 Expressing Tumors Including Small Cell Lung Cancer
Phase 1/Phase 2 · 13 location(s) · IDEAYA Biosciences · NCT07174583Spectral Analysis of Bowel Sounds in Preterm Babies of Less Than 32 Weeks of Amenorrhea (WA) as Predictive Factor of Ent
NA · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT05544097Predictive Diagnosis of Ulcero-Necrotizing EnteroColitis in Premature Babies Using an Artificial Intelligence Approach B
NA · 5 location(s) · University Hospital, Clermont-Ferrand · NCT06727877A Phase I Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HLX3901 in Patients With Advanced
Phase 1 · 2 location(s) · Shanghai Henlius Biotech · NCT07416695Characterization of Extracellular Vesicles From the Cord Blood of Extremely Preterm New Borns and Their Correlation With
Phase N/A · 1 location(s) · University Hospital, Montpellier · NCT0727364318F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 · 1 location(s) · National Cancer Institute (NCI) · NCT06503146FIRST-NEC (GFPC 01-2022) - Combination of Durvalumab With Etoposide and Platinum
Phase 2 · 31 location(s) · Centre Leon Berard · NCT06393816Mechanisms Affecting the Gut of Preterm Infants Receiving Blood Transfusion With Different Enteral Feed Interventions
Phase N/A · 1 location(s) · Imperial College Healthcare NHS Trust · NCT07191678Efficacy and Safety Evaluation of Tarlatamab in Advanced Extrapulmonary Neuroendocrine Carcinoma Patients
Phase 2 · 4 location(s) · Inkeun Park · NCT06893783ZG006 and ZG005 in Participants With Small Cell Lung Cancer or Neuroendocrine Carcinoma
Phase 1/Phase 2 · 1 location(s) · Suzhou Zelgen Biopharmaceuticals Co.,Ltd · NCT07038096A Feasibility Study to Evaluate Safety and Probable Benefit of the Eclipse XL1 System for Distraction Enterogenesis in A
NA · 6 location(s) · Eclipse Regenesis, Inc. · NCT05535361Mucous Fistula Refeeding Reduces the Time From Enterostomy Closure to Full Enteral Feeds ("MUC-FIRE" Trial)
NA · 17 location(s) · University of Leipzig · NCT03469609Diagnostic, Therapeutic and Reproductive Aspects of Patients with Mullerian Anomalies
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT04627818SVV-001 With Nivolumab and Ipilimumab in Patients With Poorly Differentiated Neuroendocrine Carcinomas (NEC) or Well-Dif
Phase 1 · 1 location(s) · Peter Hosein, MD · NCT06889493Safety and PK-PD Study of Oral L-CIT in Preterm Infants With BPD±PH and NEC
NA · 1 location(s) · The Hospital for Sick Children · NCT05636397Amniotic Fluid & the Preterm Gut
Phase N/A · 2 location(s) · Maxima Medical Center · NCT07152106SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma
Phase 1/Phase 2 · 1 location(s) · St. Jude Children's Research Hospital · NCT04923126Administration of Extracellular Vesicles From Donor Human Milk in Preterm Infants
Phase N/A · 1 location(s) · Instituto de Investigacion Sanitaria La Fe · NCT07402083Qualitative Study of Surgeons With Prospective Patient Follow-up
Phase N/A · 1 location(s) · University Hospital Southampton NHS Foundation Trust · NCT06032676A Study of MT-4561 in Patients With Various Advanced Solid Tumors
Phase 1/Phase 2 · 6 location(s) · Tanabe Pharma America, Inc. · NCT06943521Delayed Versus Immediate Cord Clamping in Preterm Birth
NA · 1 location(s) · Faculty of Medicine of Tunis · NCT07699666Efficacy and Safety of Chidamide+Sintilimab+Bev as Second-Line Therapy in Advanced Extrapulmonary Neuroendocrine Carcino
Phase 2 · 1 location(s) · Sun Yat-sen University · NCT07518602Study of Normal Intestinal Development and Disease in Premature and Term Neonates
Phase N/A · 1 location(s) · Boston Children's Hospital · NCT06681129Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Sol
Phase 1/Phase 2 · 5 location(s) · Molecular Partners AG · NCT07278479
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.